Bluejay Diagnostics, Inc. (BJDX) vs Vivos Therapeutics, Inc. (VVOS)
Bluejay Diagnostics, Inc. and Vivos Therapeutics, Inc. are both Medical Devices companies. Vivos Therapeutics, Inc. is the larger, with a market value of $4.9M against $4.3M — 1.2× the size. Vivos Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Bluejay Diagnostics, Inc. trades at 1.2×. Bluejay Diagnostics, Inc. has the higher net margin (0.00% vs −121.8%) and the higher return on invested capital (0.00% vs −592.7%). Across the 13 metrics below, Bluejay Diagnostics, Inc. leads on 9 and Vivos Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | BJDX | VVOS | Medical Devices median |
|---|---|---|---|
| Gross margin | 0.00% | 61.89% | 56.01% |
| Operating margin | 0.00% | (107.89%) | (15.03%) |
| Net margin | 0.00% | (121.79%) | (20.40%) |
| Free cash flow margin | 0.00% | (90.97%) | (7.24%) |
| Return on equity | (98.89%) | 10,022.05% | (15.32%) |
| Return on assets | (81.07%) | (101.46%) | (19.72%) |
| Return on invested capital | 0.00% | (592.70%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack